Anastasios Dimou Selected Research

Anastasios Dimou Research Topics

Disease

12	Neoplasms (Cancer) 12/2023 - 10/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 08/2011
7	Lung Neoplasms (Lung Cancer) 12/2023 - 07/2016
6	Melanoma (Melanoma, Malignant) 05/2024 - 11/2018
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2023
3	Adenocarcinoma of Lung 12/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 06/2011 - 08/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 06/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013 - 09/2012
1	Hepatitis 02/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023
1	Cytokine Release Syndrome 01/2023
1	Vesicular Stomatitis 01/2023
1	Uveal melanoma 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2020
1	Autoimmune Diseases (Autoimmune Disease) 03/2020
1	Intestinal Volvulus (Volvulus) 01/2020
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 04/2016
1	Pulmonary Embolism 11/2015
1	Diabetes Mellitus 01/2015
1	Pathologic Constriction (Stenosis) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Chronic Renal Insufficiency 01/2015
1	Proteinuria 01/2015
1	Acute Coronary Syndrome 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014
1	Atherosclerosis 01/2014
1	Venous Thromboembolism 01/2014
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 09/2013
1	Primitive Neuroectodermal Tumors (PNET) 07/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2013
1	Breast Neoplasms (Breast Cancer) 10/2012

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2012
4	ErbB Receptors (EGF Receptor)IBA 08/2021 - 06/2011
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
2	LigandsIBA 12/2023 - 01/2019
2	entrectinibIBA 11/2023 - 01/2023
2	CrizotinibIBA 11/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2016
2	Rituximab (Mabthera)FDA Link 01/2022 - 03/2020
2	osimertinibIBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2014 - 01/2014
2	Angiotensin Receptor AntagonistsIBA 12/2014 - 01/2014
2	Bevacizumab (Avastin)FDA Link 07/2013 - 06/2010
1	IpilimumabIBA 05/2024
1	NivolumabIBA 05/2024
1	cobimetinibIBA 02/2024
1	VemurafenibIBA 02/2024
1	atezolizumabIBA 02/2024
1	Protons (Proton)IBA 02/2024
1	PM 01183IBA 12/2023
1	Interferon-betaIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	taletrectinibIBA 01/2023
1	sotorasibIBA 01/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	COVID-19 VaccinesIBA 12/2022
1	pralsetinibIBA 12/2022
1	Gefitinib (Iressa)FDA Link 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	trametinibIBA 03/2020
1	dabrafenibIBA 03/2020
1	AntigensIBA 01/2020
1	GoldIBA 01/2019
1	lorlatinibIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 11/2018
1	Formaldehyde (Formol)FDA Link 04/2016
1	ParaffinIBA 04/2016
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2015
1	Proton Pump InhibitorsIBA 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Clopidogrel (Plavix)FDA Link 01/2015
1	AlbuminsIBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2014
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2014
1	Hormones (Hormone)IBA 01/2014
1	ReninIBA 01/2014
1	AngiotensinsIBA 01/2014
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2013
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2013
1	pasireotideIBA 07/2013
1	temsirolimus FDA Link 07/2013
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2013
1	pamrevlumabIBA 03/2013
1	ASG-5MEIBA 03/2013
1	tanespimycin (17AAG)IBA 03/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013
1	Connective Tissue Growth FactorIBA 03/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 10/2012

Therapy/Procedure

9	Therapeutics 02/2024 - 07/2013
6	Immunotherapy 05/2024 - 07/2016
2	Drug Therapy (Chemotherapy) 12/2023 - 03/2013
2	Radiotherapy 03/2020 - 08/2009
1	Craniospinal Irradiation 02/2024
1	Neoadjuvant Therapy 03/2019
1	Stents 01/2015